Gene · 3398
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies. | Int J Mol Sci | 2022 | 36362442 | PubTator, text mining | PubMed |
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Int J Mol Sci | 2022 | 36362359 | PubTator, text mining | PubMed |
| Zinc Finger Proteins: Functions and Mechanisms in Colon Cancer. | Cancers (Basel) | 2022 | 36358661 | PubTator, text mining | PubMed |
| Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer. | Elife | 2022 | 36346211 | PubTator, text mining | PubMed |
| Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. | Nat Genet | 2022 | 36333502 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. | Clin Transl Med | 2022 | 36333281 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Applying differential network analysis to longitudinal gene expression in response to perturbations. | Front Genet | 2022 | 36324501 | PubTator, text mining | PubMed |
| Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans. | Sci Transl Med | 2022 | 36322627 | PubTator, text mining | PubMed |
| NF kappa B regulator Bcl3 controls development and function of classical dendritic cells required for resistance to Toxoplasma gondii. | PLoS Pathog | 2022 | 36318581 | PubTator, text mining | PubMed |
| CXCR5+CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events? | Front Med (Lausanne) | 2022 | 36314014 | PubTator, text mining | PubMed |
| Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer. | Front Cell Dev Biol | 2022 | 36313549 | PubTator, text mining | PubMed |
| Integrator endonuclease drives promoter-proximal termination at all RNA polymerase II-transcribed loci. | Mol Cell | 2022 | 36309014 | PubTator, text mining | PubMed |
| Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges. | Pharmaceuticals (Basel) | 2022 | 36297340 | PubTator, text mining | PubMed |
| Regulation of Molecular Targets in Osteosarcoma Treatment. | Int J Mol Sci | 2022 | 36293439 | PubTator, text mining | PubMed |
| EGCG Prevents the Transcriptional Reprogramming of an Inflammatory and Immune-Suppressive Molecular Signature in Macrophage-like Differentiated Human HL60 Promyelocytic Leukemia Cells. | Cancers (Basel) | 2022 | 36291849 | PubTator, text mining | PubMed |
| Nuclear Proteomics of Induced Leukemia Cell Differentiation. | Cells | 2022 | 36291090 | PubTator, text mining | PubMed |
| ID2 inhibits lung adenocarcinoma cell malignant behaviors by inhibiting the activation of the PI3K/AKT/mTOR signaling pathway. | Tissue Cell | 2022 | 36274350 | PubTator, text mining | PubMed |
| Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion. | Front Immunol | 2022 | 36268015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3398/papers?page=29